← Back to news

Markets

BYD vs. Rivian: Evaluating the Better Automotive Stock to Buy for 2026

Y

Revolution Med (RVMD) Priced Rasonque at $39,800 per 30-Day Supply. Can Access Match the Clinical Breakthrough?

Y

Why Marvell Stock Rallied Today

Y

A16z-Backed OpenReserve Gets Approval for Full-Service National Bank

Y

Hormel (HRL) Expanded Adjusted Operating Margin Despite a Volume Decline. Can Cost Savings Carry the Turnaround?

Y

Murphy Oil (MUR) Strikes Black Gold While Profits Multiply Tenfold

Y

Science Applications (SAIC) Grew Revenue 6% but Posted a 0.6 Book-to-Bill Ratio. Is the $22B Backlog Enough?

Y

Dell Afterglow Continues. These Other Stocks Top Buy Points.

Y

Soybeans Fading Lower on Friday

Y

Corn Slipping Lower into the Three-Day Weekend

Y

Broadcom Crushed Earnings and the Stock Fell Anyway. Investors Are Ignoring a $230 Billion Signal.

Y

KNOT Offshore Partners LP Q2 2026 Earnings Call Summary

Y

After A Microsoft Stock Price Spike, An Options Strategy Aims For A Robust Profit In Weeks

Y

ETF Zoo: Industry Scale, Speculation, and Sports Betting

Y

Texas Multifamily Loans Flood September Foreclosures

Y

Dallas Multifamily Investors Face Tough 2027 Capital Calls

Y

Y’all Street Fuels Trophy Office Boom in Uptown Dallas

Y

Should You Brace For A Fall In American Airlines Stock?

Y

Fewer Than 30 Companies in the S&P 500 Have Raised Their Dividend for 50 Straight Years. This Financial Stock Is One of Them.

Y

Debt Management Plans: Who They Help, Who They Hurt and What They Cost

Y

With a New CEO and Majority Investors, What’s Next for HTeaO?

Y

Troubles Continue at Dickey’s as California Says the Franchisor Violated State Law, and Arbitrator Awards Illinois Franchisee $700K

Y

GameStop (GME) Plans to Use $358M of Cash to Reduce Dilution in Its Note Exchange. Is Liquidity Being Put to Better Use?

Y

IBD Stock Of The Day Exelixis Hits Earnings Snag — And Then Breaks Out

Y

Trump Issues Ultimatum to Fed: Cut Rates or Face Trade War With the World

Y

Deals & Moves: NewEdge Wealth, LPL, Osaic Poach From Rivals

Y

Trade Desk Falls 4% on 15% Workforce Cut; AppLovin Ascends 3%, Magnite Pulls Back

Y

Eric Trump wants to turn U.S. into Bitcoin leader

Y

Is AppLovin Stock Priced For A Sharper Slowdown Than Management Guides To?

Y

One of retail's once-hottest stocks just imploded 18% overnight

Y

White House has vetted candidates for key CFTC vacancies, sources tell CNBC. It's unclear if they will be filled

F

Nvidia Is Backstopping AI Boom as 'Buyer of Last Resort,' Prominent Economist Tells 'Prof G'

Y

This Oil Stock Flirts With Entry As Profits Surge 108% Amid Strait Of Hormuz Crisis

Y

How Is EOG Resources' Stock Performance Compared to Other Oil & Gas E&P Stocks?

Y

Stock Market Midday, Sept. 4: Stocks Edge Lower on Strong Jobs Report as Lululemon Plummets

Y

New Fed Chair Kevin Warsh Promised a Policy "Regime Change" to Defeat Inflation When He Took Over in January 2026. Has He Delivered?

Y

Goldman Sachs sends strong warning to bond investors

Y

Salesforce (CRM) Grew Agentforce and Data 360 ARR More Than 200%. Is AI Finally Becoming Material to Growth?

Y

Aon (AON) is Paying $17B for USI. Can $395M of Synergies Justify Another Debt-Funded Megadeal?

Y

Record Diesel Prices Push Brent Toward $95

Y

Inflation Odds Move Toward 100%

Y

BioMarin (BMRN) Secured 20% U.S. Royalties on Yuviwel. Is Monetizing a Rival Better than Blocking It?

Y

Zcash Hits Highest Price in Nearly a Decade, Crushing Short Bets

Y

Netflix Falls 4% as Rate Repricing Pressures Long-Duration Growth; Disney Dips, Warner Bros. Discovery Sits Tight

Y

Adobe Names New CEO As Earnings Approach And AI Fears Persist; Navan, SailPoint Also Due

Y

GoPro Zooms 34% Higher on Starman Optical Merger and Markiplier Stake; Coherent Climbs 7%, Lumentum Gains 3%

Y

Prediction: Vera Rubin Is About to Become a $20 Billion Windfall for Nvidia by Next Quarter

Y

Medicare Advantage Lets You In at 65 With No Questions. Medigap Asks Them Forever After. The Switch Most Retirees Can’t Make at 72.

Y

Why Fair Isaac Stock Crashed Today

Y

Lilly looks beyond obesity with $2.88B autoimmune buyout

Y